Lars Aabakken

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 155 publications

Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty.

Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty.

Journal: Scandinavian journal of gastroenterology

Published: August 04, 2026

Sustainability in endoscopic medical congresses and courses: Position Statement from the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology and Endoscopy Nurses and Associates.

Sustainability in endoscopic medical congresses and courses: Position Statement from the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology and Endoscopy Nurses and Associates.

Journal: Endoscopy

Published: May 05, 2026

Cholestatic biomarkers and symptoms in primary sclerosing cholangitis: a post-hoc analysis of the DILSTENT.

Cholestatic biomarkers and symptoms in primary sclerosing cholangitis: a post-hoc analysis of the DILSTENT.

Journal: Scandinavian journal of gastroenterology

Published: January 22, 2026

Serology-based diagnosis of coeliac disease in secondary care: a single-centre study in Norway.

Serology-based diagnosis of coeliac disease in secondary care: a single-centre study in Norway.

Journal: Scandinavian journal of gastroenterology

Published: January 16, 2026

Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma.

Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma.

Journal: JHEP reports : innovation in hepatology

Published: December 15, 2025

The Legal and Ethical Framework for Artificial Intelligence in Gastrointestinal Endoscopy: A World Endoscopy Organization International Consensus Statement.

The Legal and Ethical Framework for Artificial Intelligence in Gastrointestinal Endoscopy: A World Endoscopy Organization International Consensus Statement.

Journal: Annals of internal medicine

Published: December 08, 2025

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: November 11, 2025

Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease.

Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: October 17, 2025

Research Communication: Teriflunomide Does Not Affect Gluten-Specific T-Cell Activity in Coeliac Disease-A Randomised, Placebo-Controlled Trial.

Research Communication: Teriflunomide Does Not Affect Gluten-Specific T-Cell Activity in Coeliac Disease-A Randomised, Placebo-Controlled Trial.

Journal: Alimentary pharmacology & therapeutics

Published: June 24, 2025

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits.

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits.

Journal: JHEP reports : innovation in hepatology

Published: June 19, 2025

WEO Position Statement on Telementoring in Gastrointestinal Endoscopy.

WEO Position Statement on Telementoring in Gastrointestinal Endoscopy.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: March 30, 2025

Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy.

Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy.

Journal: Scandinavian journal of immunology

Published: March 28, 2025

Showing 1-12 of 155

Last Updated: 09/26/2026